GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 105 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $10,301,000 | +1694.6% | 430,984 | +965.8% | 0.04% | +2150.0% |
| Q3 2020 | $574,000 | -24.5% | 40,439 | -21.7% | 0.00% | -50.0% |
| Q2 2020 | $760,000 | +125.5% | 51,639 | -26.3% | 0.00% | +300.0% |
| Q4 2019 | $337,000 | -41.6% | 70,054 | -26.5% | 0.00% | -50.0% |
| Q3 2019 | $577,000 | -39.1% | 95,254 | -34.8% | 0.00% | -33.3% |
| Q2 2019 | $948,000 | -7.0% | 146,100 | +1.7% | 0.00% | -25.0% |
| Q1 2019 | $1,019,000 | +961.5% | 143,700 | +858.0% | 0.00% | – |
| Q2 2018 | $96,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 950,000 | $9,823,000 | 1.01% |
| Curi RMB Capital, LLC | 939,265 | $9,720,000 | 0.74% |
| KOPP INVESTMENT ADVISORS LLC | 96,384 | $997,000 | 0.39% |
| Alyeska Investment Group, L.P. | 314,502 | $3,254,000 | 0.16% |
| PFM Health Sciences, LP | 604,199 | $6,252,000 | 0.13% |
| Spark Investment Management LLC | 47,000 | $485,000 | 0.13% |
| ELLINGTON MANAGEMENT GROUP LLC | 61,700 | $638,000 | 0.12% |
| PUTNAM INVESTMENTS LLC | 1,745,494 | $18,048,000 | 0.05% |
| PointState Capital LP | 298,976 | $3,094,000 | 0.05% |
| Partner Investment Management, L.P. | 20,717 | $214,000 | 0.05% |